New funding awards - September 2021

Friday, October 29, 2021

Sponsored Research 

Melissa Daubert of Cardiology has received an award from the National Institutes of Health for a project entitled "Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study." Total funding will be $7,892,380.

Adrian Hernandez of Cardiology has received an award from the National Institutes of Health for a project entitled "Collaboratory Resource Coordinating Center for Pragmatic and Implementation Studies for the Management of Pain (PRISM) (U24)." Total funding will be $6,249,316.

Jonathan Piccini of Cardiology has received a sub-award through the American Heart Association for a project entitled "CHANGE AF." Total funding will be $4,837,487.

Geoffrey Ginsburg of Cardiology has received an award from the National Institutes of Health for a project entitled "The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination." Total funding will be $367,358.

Adrian Hernandez of Cardiology has received an award from the National Institutes of Health for a project entitled "HEAL Collaboratory Resource Coordinating Center (PRISM) (U24): Bioethics Supplement." Total funding will be $191,152.

William Kraus of Cardiology has received an award from the National Institutes of Health for a project entitled "Molecular Transducers of Physical Activity and Health: NC Consortium Clinical Site Supplement." Total funding will be $128,314.

Michel Khouri of Cardiology has received an award from the Cedars Sinai Medical Center for a project entitled "The Cardiac Amloidosis Registry Study." Total funding has yet to be determined.

Industry Sponsored Clinical Trials 

Manal Abdelmalek of Gastroenterology has received an award from Akero Therapeutics, Inc for a project entitled "Akero AK-US-001-0102 A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled study evaluating the safety and efficacy of Efruxifemin in Non-Cirrhotic subject with Nonalcoholic Steatohepatitis (NASH)." Total funding will be $492,492.

Manal Abdelmalek of Gastroenterology has received an award from NGM Biopharmaceuticals, Inc. for a project entitled "NGM 282-OR-208." Total funding will be $47,141.

Matthew Kappus of Gastroenterology has received an award from Impedimed for a project entitled "Research Device Loan for FrAILT Study." Total funding has yet to be determined.

James Davis of General Internal Medicine has received an award from Predictably Human, Inc for a project entitled "Aerosol Acceptability PIL & Technology Comprehension Study." Total funding will be $708,268.

Rowena Dolor of General Internal Medicine has received an award from COPD Foundation Inc for a project entitled "COVID-19 Cleaning - The CAPTURE Study: Validating a unique COPD screening tool in primary care." Total funding has yet to be determined.

Harry Erba of Hematologic Malignancies and Cellular Therapy has received an award from ALX Oncology for a project entitled "AT148005." Total funding will be $1,249,979.

Harry Erba of Hematologic Malignancies and Cellular Therapy has received an award from Servier Pharmaceuticals for a project entitled "A Multi-center, Open-label, Single-arm Phase 2/3 Trial Evaluating the Safety and Pharmacokinetics of Calaspargase Pegol for Treatment of Adults Aged 22 To > 65 Years with Newly-diagnosed Philadelphia-negative ALL." Total funding will be $484,199.

Danielle Brander of Hematologic Malignancies and Cellular Therapy has received an award from Catapult Therapeutics BV for a project entitled "An Open Label Phase Ia/B Dose Escalation Followed By Dose Expansion Safety And Tolerability Trial Of Cap 100, A Humanized C C Chemokine Receptor 7 Antibody, Administered As Monotherapy In Subjects With R/R Chronic Lymphocytic Leukemia." Total funding will be $222,169.

Carlos Decastro of Hematologic Malignancies and Cellular Therapy has received an award from Novartis Pharmaceuticals Corporation for a project entitled "A randomized, multicenter, active-comparator controlled, open-label trial to evaluate efficacy and safety of oral, twice daily LNP023 in adult patients with PNH and residual anemia, despite treatment with intravenous anti-C5 antibody." Total funding will be $149,455.

Nirmish Shah of Hematology has received an award from Global Blood Therapeutics, Inc. for a project entitled "GBT 440-4R1 Retrospective Registry." Total funding will be $255,805.

Michael Harrison of Medical Oncology has received an award from Merck Sharp & Dohme for a project entitled "Title A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants with RCC (Substudy U03A)." Total funding will be $2,511,311.

Jennifer Choe of Medical Oncology has received an award from Adlai Nortye Ltd for a project entitled "The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. AN2025H0301." Total funding will be $676,063.

James Abbruzzese of Medical Oncology has received an award from Pfizer, Inc. for a project entitled "A Phase 1 Dose Escalation And Expansion Study Evaluating The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Antitumor Activity Of Pf-07257876 In Patients With Advanced Or Metastatic Tumors." Total funding will be $363,122.

Richard Riedel of Medical Oncology has received an award from BioAtla, Inc for a project entitled "A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3011 Alone and in Combination with Nivolumab in Adult and Adolescent Patients 12 Years and Older with Advanced Solid Tumors." Total funding will be $330,638.

Andrew Nixon of Medical Oncology has received an award from Alliance Foundation Trials, LLC for a project entitled "A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent or Persistent Endometrial Cancer." Total funding has yet to be determined.

Aparna Swaminathan of Pulmonary has received an award from Genentech, Inc. for a project entitled "Characterizing The Ild Care Continuum Using Real-World Evidence." Total funding will be $343,183.